Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-21

FDA Approved: MESALAMINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves the original application for MESALAMINE from Zydus Lifesciences Limited for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)